Kaye Edward M. MD sold STOK
December 8, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 8,274 shares of Stoke Therapeutics, Inc. at $32.52 per share, a transaction worth $269.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,274
Price
$32.52
Total value
$269.1K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after50,455
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.95 per share, inclusive.